These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 18396507)
21. Van Gogh and lithium. Creativity and bipolar disorder: perspective of a writer/photographer. Dennison D Aust N Z J Psychiatry; 1999 Dec; 33 Suppl():S111-3. PubMed ID: 10622187 [TBL] [Abstract][Full Text] [Related]
22. Benzodiazepines may reduce the effectiveness of ketamine in the treatment of depression. Ford N; Ludbrook G; Galletly C Aust N Z J Psychiatry; 2015 Dec; 49(12):1227. PubMed ID: 26058787 [No Abstract] [Full Text] [Related]
23. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials. Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028 [TBL] [Abstract][Full Text] [Related]
24. [Persistent cerebellar syndrome after treatment with lithium and a neuroleptic]. Merle C; Sotto A; Galland MC; Jourdan E; Jourdan J Therapie; 1998; 53(5):511-3. PubMed ID: 9921050 [No Abstract] [Full Text] [Related]
25. Valproic Acid-related anticonvulsant hypersensitivity syndrome and subsequent olanzapine-related neutropenia and thrombocytopenia: a case report. Lin YH; Chien YL J Clin Psychopharmacol; 2012 Feb; 32(1):132-3. PubMed ID: 22217947 [No Abstract] [Full Text] [Related]
26. Combination therapy versus monotherapy in bipolar disorder. Ketter TA J Clin Psychiatry; 2008 Dec; 69(12):e34. PubMed ID: 19203484 [TBL] [Abstract][Full Text] [Related]
28. Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: an open-label study. Schüle C; Baghai TC; Eser D; Nothdurfter C; Rupprecht R World J Biol Psychiatry; 2009; 10(4 Pt 2):390-9. PubMed ID: 18609420 [TBL] [Abstract][Full Text] [Related]
29. Commercial and non-commercial 'championing' of medications. Parry P Aust N Z J Psychiatry; 2010 Jun; 44(6):585. PubMed ID: 20482422 [No Abstract] [Full Text] [Related]
34. Adding lithium or anticonvulsants to antipsychotics for the treatment of schizophrenia: useful strategy or exercise in futility? Citrome L J Clin Psychiatry; 2009 Jun; 70(6):932-3. PubMed ID: 19573487 [No Abstract] [Full Text] [Related]
35. Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania. Baker RW; Brown E; Akiskal HS; Calabrese JR; Ketter TA; Schuh LM; Trzepacz PT; Watkin JG; Tohen M Br J Psychiatry; 2004 Dec; 185():472-8. PubMed ID: 15572737 [TBL] [Abstract][Full Text] [Related]
36. Long-term safety and efficacy of secukinumab in patients with psoriasis and major psychiatric disorders: a case series. Esposito M; Giunta A; Del Duca E; Manfreda V; Troisi A; Bianchi L; Fargnoli MC Postgrad Med; 2020 Mar; 132(2):172-175. PubMed ID: 31916470 [No Abstract] [Full Text] [Related]
37. Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine. Fava M; Alpert J; Nierenberg A; Lagomasino I; Sonawalla S; Tedlow J; Worthington J; Baer L; Rosenbaum JF J Clin Psychopharmacol; 2002 Aug; 22(4):379-87. PubMed ID: 12172337 [TBL] [Abstract][Full Text] [Related]